Prostate Cancer
Research


Volume 7 Number 8
August 2019


Home > Disciplines > Publications > Prostate Cancer Research > Volume 7, Year 2019 > Number 8, August



CONTENTS


DIAGNOSIS
FOLLOW-UP, QUALITY OF LIFE
PROGNOSIS
TREATMENT



DIAGNOSIS

.

Calais J, Ceci F, Eiber M, Hope TA, Hofman MS, Rischpler C, Bach-Gansmo T, Nanni C, Savir-Baruch B, Elashoff D, Grogan T, Dahlbom M, Slavik R, Gartmann J, Nguyen K, Lok V, Jadvar H, Kishan AU, Rettig MB, Reiter RE, Fendler WP, Czernin J.
18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial.
Lancet Oncol. 2019 Sep;20(9):1286-1294. doi: 10.1016/S1470-2045(19)30415-2. Epub 2019 Jul 30.
Source | Full text | Similar articles



.

Couñago F, Díaz Gavela AA, Sancho G, Ortiz I, Marcos FJ, Recio M, Fernández J, Cano R, Jiménez M, Thuissard IJ, Sanz-Rosa D, Castro Nováis J, Pardo E, Molina Y, Pérez García H, Del Cerro E.
Multiparametric magnetic resonance imaging-guided salvage radiotherapy in prostate cancer.
Rep Pract Oncol Radiother. 2019 Sep-Oct;24(5):472-480. doi: 10.1016/j.rpor.2019.07.008. Epub 2019 Aug 8.
Source | Full text | Similar articles



.

Choyke P.
Editorial: assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer, a prospective single arm clinical study: California shows the way!
Transl Androl Urol. 2019 Jul;8(Suppl 3):S296-S299. doi: 10.21037/tau.2019.06.11.
Source | Full text | Similar articles
Referring to: Fendler WP, et al, Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial. JAMA Oncol. 2019 Jun 1;5(6):856-863. doi: 10.1001/jamaoncol.2019.0096. Source / Full text / Similar articles



.

Dell'Oglio P, Stabile A, Soligo M, Brembilla G, Esposito A, Gandaglia G, Fossati N, Bravi CA, Dehò F, De Cobelli F, Montorsi F, Karnes RJ, Briganti A.
There Is No Way to Avoid Systematic Prostate Biopsies in Addition to Multiparametric Magnetic Resonance Imaging Targeted Biopsies.
Eur Urol Oncol. 2019 Mar 27. pii: S2588-9311(19)30033-1. doi: 10.1016/j.euo.2019.03.002. [Epub ahead of print]
Source | Full text | Similar articles



.

Fendler WP, Calais J, Eiber M, Flavell RR, Mishoe A, Feng FY, Nguyen HG, Reiter RE, Rettig MB, Okamoto S, Emmett L, Zacho HD, Ilhan H, Wetter A, Rischpler C, Schoder H, Burger IA, Gartmann J, Smith R, Small EJ, Slavik R, Carroll PR, Herrmann K, Czernin J, Hope TA.
Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial.
JAMA Oncol. 2019 Jun 1;5(6):856-863. doi: 10.1001/jamaoncol.2019.0096.
Source | Full text | Similar articles



.

Kranzbühler B, Müller J, Becker AS, Garcia Schüler HI, Muehlematter UJ, Fankhauser CD, Kedzia S, Guckenberger M, Kaufmann PA, Eberli D, Burger IA.
Detection rate and localization of prostate cancer recurrence using 68Ga-PSMA-11 PET/MRI in patients with low PSA values ≤ 0.5 ng/ml.
J Nucl Med. 2019 Aug 2. pii: jnumed.118.225276. doi: 10.2967/jnumed.118.225276. [Epub ahead of print]
Source | Full text | Similar articles



.

Miah S, Hosking-Jervis F, Connor MJ, Eldred-Evans D, Shah TT, Arya M, Barber N, Bhardwa J, Bott S, Burke D, Doherty A, Foster C, Freeman A, Hindley R, Jameson C, Karim O, Laniado M, Montgomery B, Nigam R, Punwani S, Sinclair A, Winkler M, Allen C, Ahmed HU.
A Multicentre Analysis of the Detection of Clinically Significant Prostate Cancer Following Transperineal Image-fusion Targeted and Nontargeted Systematic Prostate Biopsy in Men at Risk.
Eur Urol Oncol. 2019 Mar 29. pii: S2588-9311(19)30038-0. doi: 10.1016/j.euo.2019.03.005. [Epub ahead of print]
Source | Full text | Similar articles



.

Rousseau C, Le Thiec M, Ferrer L, Rusu D, Rauscher A, Maucherat B, Frindel M, Baumgartner P, Fleury V, Denis A, Morel A, Varmenot N, Debeaupuis E, Campion L, Kraeber-Bodéré F.
Preliminary results of a 68 Ga-PSMA PET/CT prospective study in prostate cancer patients with occult recurrence: Diagnostic performance and impact on therapeutic decision-making.
Prostate. 2019 Sep;79(13):1514-1522. doi: 10.1002/pros.23869. Epub 2019 Aug 17.
Source | Full text | Similar articles



.

van Leenders GJLH, Kweldam CF, Hollemans E, Kümmerlin IP, Nieboer D, Verhoef EI, Remmers S, Incrocci L, Bangma CH, van der Kwast TH, Roobol MJ.
Improved Prostate Cancer Biopsy Grading by Incorporation of Invasive Cribriform and Intraductal Carcinoma in the 2014 Grade Groups.
Eur Urol. 2019 Aug 19. pii: S0302-2838(19)30612-8. doi: 10.1016/j.eururo.2019.07.051. [Epub ahead of print]
Source | Full text | Similar articles



FOLLOW-UP, QUALITY OF LIFE

.

Della Camera PA, Tellini R, Cito G, Rastrelli G, Maggi M, Chini T, Nunzio C, Altieri VM, Serni S, Gacci M, Natali A.
Efficacy and safety of avanafil 200 mg versus sildenafil 100 mg in the treatment of erectile dysfunction after robot-assisted unilateral nerve-sparing prostatectomy: A prospective multicentre study.
Urologia. 2019 Aug 23:391560319867809. doi: 10.1177/0391560319867809. [Epub ahead of print]
Source | Full text | Similar articles



PROGNOSIS

.

Cook GJR, Kulkarni M, Warbey VS.
PSMA PET/CT imaging for primary staging of intermediate and high-risk prostate cancer.
BJU Int. 2019 Sep;124(3):357-358. doi: 10.1111/bju.14856.
Source | Full text | Similar articles
Editorial referring to: Yaxley JW, et al, Risk of metastatic disease on 68 gallium-prostate-specific membrane antigen positron emission tomography/computed tomography scan for primary staging of 1253 men at the diagnosis of prostate cancer.
BJU Int. 2019 Sep;124(3):401-407. doi: 10.1111/bju.14828. Epub 2019 Jul 2.
Source / Full text / Similar articles



.

Martini A, Gandaglia G, Fossati N, Scuderi S, Bravi CA, Mazzone E, Stabile A, Scarcella S, Robesti D, Barletta F, Cucchiara V, Mirone V, Montorsi F, Briganti A.
Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer.
Eur Urol Oncol. 2019 Apr 4. pii: S2588-9311(19)30039-2. doi: 10.1016/j.euo.2019.03.006. [Epub ahead of print]
Source | Full text | Similar articles



.

Miyake M, Tanaka N, Asakawa I, Owari T, Hori S, Morizawa Y, Nakai Y, Inoue T, Anai S, Torimoto K, Hasegawa M, Fujii T, Konishi N, Fujimoto K.
The impact of the definition of biochemical recurrence following salvage radiotherapy on outcomes and prognostication in patients with recurrent prostate cancer after radical prostatectomy: a comparative study of three definitions.
Prostate Int. 2019 Jun;7(2):47-53. doi: 10.1016/j.prnil.2018.04.005. Epub 2018 May 5.
Source | Full text | Similar articles



.

Preisser F, Bandini M, Nazzani S, Mazzone E, Marchioni M, Tian Z, Chun FKH, Saad F, Briganti A, Haese A, Montorsi F, Huland H, Graefen M, Tilki D, Karakiewicz PI.
Development and Validation of a Lookup Table for the Prediction of Metastatic Prostate Cancer According to Prostatic-specific Antigen Value, Clinical Tumor Stage, and Gleason Grade Groups.
Eur Urol Oncol. 2019 Mar 28. pii: S2588-9311(19)30035-5. doi: 10.1016/j.euo.2019.03.003. [Epub ahead of print]
Source | Full text | Similar articles



.

Radtke JP, Giganti F, Wiesenfarth M, Stabile A, Marenco J, Orczyk C, Kasivisvanathan V, Nyarangi-Dix JN, Schütz V, Dieffenbacher S, Görtz M, Stenzinger A, Roth W, Freeman A, Punwani S, Bonekamp D, Schlemmer HP, Hohenfellner M, Emberton M, Moore CM.
Prediction of significant prostate cancer in biopsy-naïve men: Validation of a novel risk model combining MRI and clinical parameters and comparison to an ERSPC risk calculator and PI-RADS.
PLoS One. 2019 Aug 26;14(8):e0221350. doi: 10.1371/journal.pone.0221350. eCollection 2019.
Source | Full text | Similar articles



.

Sato S, Kimura T, Yorozu T, Onuma H, Iwatani K, Egawa S, Ikegami M, Takahashi H.
Cases Having a Gleason Score 3+4=7 With <5% of Gleason Pattern 4 in Prostate Needle Biopsy Show Similar Failure-free Survival and Adverse Pathology Prevalence to Gleason Score 6 Cases in a Radical Prostatectomy Cohort.
Am J Surg Pathol. 2019 Aug 20. doi: 10.1097/PAS.0000000000001345. [Epub ahead of print]
Source | Abstract | Similar articles



.

Vau N, Henriques V, Cheng L, Blanca A, Fonseca J, Montironi R, Cimadamore A, Lopez-Beltran A.
Predicting biochemical recurrence after radical prostatectomy: the role of prognostic grade group and index tumor nodule.
Hum Pathol. 2019 Aug 20. pii: S0046-8177(19)30151-0. doi: 10.1016/j.humpath.2019.08.012. [Epub ahead of print]
Source | Full text | Similar articles



.

Yaxley JW, Raveenthiran S, Nouhaud FX, Samaratunga H, Yaxley WJ, Coughlin G, Yaxley AJ, Gianduzzo T, Kua B, McEwan L, Wong D.
Risk of metastatic disease on 68 gallium-prostate-specific membrane antigen positron emission tomography/computed tomography scan for primary staging of 1253 men at the diagnosis of prostate cancer.
BJU Int. 2019 Sep;124(3):401-407. doi: 10.1111/bju.14828. Epub 2019 Jul 2.
Source | Full text | Similar articles



.

Zhu X, Gou X, Zhou M.
Nomograms Predict Survival Advantages of Gleason Score 3+4 Over 4+3 for Prostate Cancer: A SEER-Based Study.
Front Oncol. 2019 Jul 16;9:646. doi: 10.3389/fonc.2019.00646. eCollection 2019.
Source | Full text | Similar articles



TREATMENT

.

Deek MP, Yu C, Phillips R, Song DY, Deville C, Greco S, DeWeese TL, Antonarakis ES, Markowski M, Paller C, Denmeade S, Carducci M, Walsh PC, Pienta KJ, Eisenberger M, Tran PT.
Radiotherapy In The Definitive Management Of Oligometastatic Prostate Cancer: The Johns Hopkins Experience.
Int J Radiat Oncol Biol Phys. 2019 Aug 13. pii: S0360-3016(19)33641-7. doi: 10.1016/j.ijrobp.2019.08.008. [Epub ahead of print]
Source | Full text | Similar articles



.

Hackman G, Taari K, Tammela TL, Matikainen M, Kouri M, Joensuu T, Luukkaala T, Salonen A, Isotalo T, Pétas A, Hendolin N, Boström PJ, Aaltomaa S, Lehtoranta K, Hellström P, Riikonen J, Korpela M, Minn H, Kellokumpu-Lehtinen PL, Pukkala E, Hemminki A; FinnProstate Group.
Randomised Trial of Adjuvant Radiotherapy Following Radical Prostatectomy Versus Radical Prostatectomy Alone in Prostate Cancer Patients with Positive Margins or Extracapsular Extension.
Eur Urol. 2019 Jul 17. pii: S0302-2838(19)30525-1. doi: 10.1016/j.eururo.2019.07.001. [Epub ahead of print]
Source | Full text | Similar articles



.

Poulsen MH, Jakobsen JS, Mortensen MA, Høilund-Carlsen PF, Lund L.
Does therapy of the primary tumor matter in oligometastatic prostate cancer? A prospective 10-year follow-up study.
Res Rep Urol. 2019 Jul 30;11:215-221. doi: 10.2147/RRU.S190140. eCollection 2019.
Source | Full text | Similar articles



.

Zilli T, Franzese C, Bottero M, Giaj-Levra N, Förster R, Zwahlen D, Koutsouvelis N, Bertaut A, Blanc J, Roberto D'agostino G, Alongi F, Guckenberger M, Scorsetti M, Miralbell R.
Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial.
Radiother Oncol. 2019 Aug 17. pii: S0167-8140(19)33011-7. doi: 10.1016/j.radonc.2019.07.018. [Epub ahead of print]
Source | Full text | Similar articles



bottom